The Readout Loud

350 Odcinki

1. 268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading

   Opublikowany: 27.07.2023
2. 267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford

   Opublikowany: 20.07.2023
3. 266: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads

   Opublikowany: 13.07.2023
4. 265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

   Opublikowany: 29.06.2023
5. 264: Messy PBM conflicts, debatable vaccines, & the future of flu season

   Opublikowany: 22.06.2023
6. 263: Biogen's messy board, Laronde's data problem, & the downside of a boom

   Opublikowany: 15.06.2023
7. 262: Merck v. USA, the best of ASCO, and Leqembi at the FDA

   Opublikowany: 8.06.2023
8. 261: Fake medical devices, real cancer drugs, & curious Ozempic effects

   Opublikowany: 1.06.2023
9. 260: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA

   Opublikowany: 25.05.2023
10. 259: The FTC v. Amgen, Sarepta's future, & Galapagos' turnaround

    Opublikowany: 18.05.2023
11. 258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry

    Opublikowany: 11.05.2023
12. 257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business

    Opublikowany: 4.05.2023
13. 256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

    Opublikowany: 27.04.2023
14. 255: Sarepta's pivotal moment, biotech's big week, & the future of Covid boosters

    Opublikowany: 20.04.2023
15. 254: The legal battle over abortion, an FDA 'bully pulpit' and Moderna's future

    Opublikowany: 13.04.2023
16. 253: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

    Opublikowany: 6.04.2023
17. 252: Biotech's monkey shortage, the broken generics market, & conference cancel culture

    Opublikowany: 30.03.2023
18. 251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster

    Opublikowany: 23.03.2023
19. 250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

    Opublikowany: 16.03.2023
20. 249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity

    Opublikowany: 9.03.2023